Sea Otter Advisors’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Sea Otter Advisors’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,557	Closed	-$3.06K	–	29
2024 Q2	$3.06K	Hold	10,557	–	–	0.02%	39
2024 Q1	$152K	Buy	+10,557	New	+$126K	0.74%	25
2023 Q4	–	Sell	-10,558	Closed	-$158K	–	238
2023 Q3	$158K	Hold	10,558	–	–	0.09%	97
2023 Q2	$219K	Hold	10,558	–	–	0.12%	95
2023 Q1	$93.1K	Buy	+10,558	New	+$128K	0.05%	143

Other funds holding EFTR

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Sea Otter Advisors's EFTR Position: Q3 2024 in Review

Sea Otter Advisors sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 10,557 shares — an estimated $3.06K sold.

Sea Otter Advisors first reported a position in EFTR in Q1 2023 and held it in 5 quarters. The position peaked at $219K in Q2 2023. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

Sea Otter Advisors reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Sea Otter Advisors sold 10,557 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $3.06K.
Sea Otter Advisors first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
Sea Otter Advisors's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $219K in Q2 2023.
3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Sea Otter Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.